DHA vs EPA: which omega-3 matters most for your goal

You stand in the supplement aisle staring at three fish oil bottles. One label boasts “high DHA.” Another claims “concentrated EPA.” The third offers a 50/50 blend. They all say “omega-3” and they all claim to support heart and brain health. So which one should you actually buy?

The honest answer: it depends on what you are trying to achieve. DHA and EPA are both omega-3 fatty acids, both found in fish oil, and both essential for health — but they are structurally different molecules with distinct biological roles. DHA is the primary structural fat in your brain and retina. EPA is the more potent anti-inflammatory. Their effects on cardiovascular disease, cognitive aging, mood, and longevity are not interchangeable.

Understanding this distinction is worth more than any brand preference. Here is what the science actually shows.

What you’ll learn:

• The structural and functional differences between DHA and EPA
• Which omega-3 is more important for brain health, heart disease, inflammation, and mood
• What the Omega-3 Index is and why it matters for longevity
• How to choose the right EPA:DHA ratio for your specific health goals

---

Quick answer

EPA and DHA are not interchangeable. EPA is usually the better target for triglycerides, systemic inflammation, and mood-support formulations; DHA is the better target for brain, retina, pregnancy-related structural needs, and cognitive-aging support.

For general longevity, the goal is usually not choosing one and ignoring the other. It is reaching an adequate combined EPA+DHA blood level, then adjusting the EPA:DHA ratio to your primary goal.

High-dose omega-3 is not automatically better. Prescription-level doses can lower triglycerides, but trials also show a dose-related atrial-fibrillation signal, so people with arrhythmia risk or anticoagulant use should involve a clinician.

Key facts

• DHA -> structure: concentrated in brain and retinal membranes, where it supports membrane fluidity and neural signaling.
• EPA -> signaling: competes with arachidonic acid and supports anti-inflammatory and triglyceride-lowering pathways.
• Omega-3 Index -> status: EPA+DHA in red blood cells is a useful biomarker, but mortality links are observational, not a guarantee.
• REDUCE-IT -> context: the strongest event data came from prescription icosapent ethyl in high-risk statin-treated patients, not generic fish oil.
• AF risk -> dose caution: meta-analyses of cardiovascular trials show a higher atrial-fibrillation signal, especially at higher doses.
• Food first -> supplement second: fatty fish or algae can cover baseline needs; supplements are most useful when intake or blood levels stay low.

What are DHA and EPA?

DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid) are long-chain polyunsaturated fatty acids belonging to the omega-3 family. Both are synthesized from alpha-linolenic acid (ALA), the plant-based omega-3 found in flaxseed and walnuts — but this conversion is extremely inefficient in humans, typically below 5–10% for EPA and below 1% for DHA.

Quick definition: DHA is a 22-carbon omega-3 fatty acid that serves as the primary structural lipid in brain and retinal membranes. EPA is a 20-carbon omega-3 fatty acid that serves as the primary precursor for anti-inflammatory signaling molecules called resolvins and protectins.

Property	DHA	EPA
Carbon chain	22 carbons, 6 double bonds	20 carbons, 5 double bonds
Primary location	Brain, retina, sperm cell membranes	Cell membranes throughout the body
Primary function	Structural (membrane fluidity, signaling)	Functional (anti-inflammatory mediator)
Brain content	~40% of brain polyunsaturated fats	~1–2% of brain polyunsaturated fats
Dietary sources	Fatty fish, algae	Fatty fish, algae

Why this comparison matters for your health

Most people consume omega-3 supplements without considering the EPA:DHA ratio. Yet clinical trials increasingly show that the optimal ratio depends on the target condition. A person supplementing for depression benefits most from EPA-dominant formulations. A person supplementing for neuroprotection benefits most from DHA. Getting this wrong does not cause harm — but it means leaving efficacy on the table.

---

The science behind the comparison

How DHA works in the body

DHA is the major structural omega-3 in the brain and retina. Its long, flexible carbon chain helps neuronal and photoreceptor membranes stay fluid enough for signaling. DHA also gives rise to specialized pro-resolving mediators such as neuroprotectin D1, which is why DHA is usually prioritized for brain, retina, pregnancy-related structural needs, and cognitive-aging support.

This does not mean DHA is a stand-alone brain upgrade. Human outcomes depend on baseline status, diet quality, age, genetics, and whether EPA+DHA blood levels actually rise.

How EPA works in the body

EPA is more directly tied to inflammatory signaling and triglyceride metabolism. It competes with arachidonic acid for COX and LOX enzymes and helps produce E-series resolvins, shifting the balance away from persistent inflammatory signaling.

EPA-dominant formulas have the clearest role when the goal is triglyceride lowering, systemic inflammation support, or mood-support adjuncts. The effect is still context-dependent: dose, baseline inflammation, medications, and cardiovascular risk all matter.

DHA, EPA, and longevity: what the research says

The Omega-3 Index measures EPA+DHA as a percentage of red blood cell fatty acids. Higher circulating long-chain omega-3 levels have been associated with lower all-cause and cardiovascular mortality in large prospective cohorts, including a 2021 pooled analysis from 17 studies.

That evidence is observational, so it should not be read as a promise that taking fish oil will lower mortality by a fixed amount. The practical use is simpler: test your status if possible, aim for an adequate EPA+DHA range, and choose the ratio that fits your goal.

---

Head-to-head comparison by health goal

Brain health and cognitive aging

Winner: DHA

DHA is the dominant structural omega-3 in the brain. Higher DHA blood levels are associated with larger brain volume in aging adults and reduced risk of Alzheimer’s disease. DHA also supports the production of BDNF, the neurotrophic factor most critical for neuroplasticity and memory. A randomized controlled trial in American football players found that DHA supplementation reduced neurofilament light (NfL) — a biomarker of neuronal damage — in a dose-dependent manner.

EPA’s role in the brain is secondary: it supports neuronal health primarily through its anti-inflammatory effects rather than structural incorporation. For cognitive decline prevention, DHA should be the priority.

Recommendation: For brain health, choose a supplement with a higher DHA:EPA ratio (e.g., 2:1 or 3:1).

Heart disease and cardiovascular health

Winner: EPA for triglycerides and selected high-risk cardiovascular contexts; mixed for generic prevention.

The strongest event evidence comes from REDUCE-IT, which tested prescription icosapent ethyl (pure EPA) at 4 g/day in statin-treated, high-risk patients with elevated triglycerides. That result should not be generalized to every over-the-counter fish-oil product or to low-risk people taking a casual dose.

Cardiovascular target	More relevant omega-3	Evidence note
Triglyceride reduction	EPA or EPA+DHA, often prescription dose	Strongest at about 4 g/day under clinician care
Blood pressure and heart rate	Often DHA or combined EPA+DHA	Modest effects, not a medication substitute
Inflammatory signaling	EPA-dominant	Mechanistically strong, clinical response varies
Cardiovascular events	Prescription EPA in REDUCE-IT context	Not equivalent to generic fish oil
Atrial fibrillation caution	Dose-related signal for omega-3 products	Discuss high doses if you have AF risk

Important caveat on atrial fibrillation: meta-analyses of cardiovascular outcome trials report a higher relative risk of atrial fibrillation with marine omega-3 supplementation, with stronger signals at higher doses. This does not mean normal fish intake is dangerous; it means high-dose supplementation should be individualized.

Recommendation: for triglycerides or high cardiovascular risk, work with a clinician and favor evidence-based EPA dosing. For general heart health, prioritize fish intake, overall diet quality, exercise, and blood-pressure/lipid management before chasing a high-dose supplement.

Inflammation and inflammatory aging

Winner: EPA

EPA is the more potent systemic anti-inflammatory, primarily because it competes with arachidonic acid for COX-2 enzyme access and generates anti-inflammatory resolvins. Clinical trials consistently show that EPA-dominant supplements reduce hsCRP, TNF-α, and IL-6 more effectively than DHA-dominant supplements. For a complementary approach, curcumin inhibits the same NF-κB and COX-2 pathways through a different mechanism, making it a natural pairing with EPA.

However, DHA’s brain-specific anti-inflammatory role (via neuroprotectin D1) means it is superior for neuroinflammation specifically.

Recommendation: For systemic inflammation (high hsCRP, joint pain, metabolic syndrome), choose EPA-dominant. For neuroinflammation, choose DHA.

Depression and mood disorders

Winner: EPA

A 2019 meta-analysis of 26 randomized controlled trials concluded that EPA — not DHA — was the effective component for reducing depressive symptoms. Formulations with EPA ≥60% of total omega-3 content showed significant antidepressant effects; pure DHA formulations did not.

The mechanism likely involves EPA’s ability to reduce neuroinflammation and modulate serotonin receptor sensitivity — both implicated in the inflammatory theory of depression.

Recommendation: For mood support, choose EPA-dominant formulations (≥60% EPA).

Eye health

Winner: DHA

DHA constitutes 60% of the polyunsaturated fatty acids in retinal photoreceptor membranes. Higher DHA intake is associated with reduced risk of age-related macular degeneration (AMD). The AREDS2 trial tested omega-3 supplementation but used a combined EPA+DHA formulation, making it difficult to isolate DHA’s contribution.

Recommendation: For eye health, DHA-dominant or balanced formulations.

---

How much do you need?

General guidelines by goal

Health goal	Typical EPA+DHA range	Preferred ratio	Important caveat
General health	250-1,000 mg/day	Balanced	Food can be enough for many people
Brain, retina, pregnancy-related structural support	500-1,500 mg/day	DHA-dominant	Pregnancy dosing should follow clinician guidance
Triglycerides	2,000-4,000 mg/day	Often EPA-dominant or prescription	Use clinician oversight at high doses
Inflammation	1,000-3,000 mg/day	EPA-dominant	Reassess symptoms and labs after 8-12 weeks
Mood support	1,000-2,000 mg EPA/day	EPA at least 60% of formula	Adjunct only; not a replacement for care

Target Omega-3 Index

The Omega-3 Index is a useful status marker because it reflects EPA+DHA in red blood cells over time. Many clinicians and testing companies use 8-12% as a desirable range, while many Western populations average closer to 4-5%. Treat the number as a risk marker and tracking tool, not as a guaranteed outcome target.

If your index is low, a common approach is to increase fatty fish or algae intake first, then retest after about 3-4 months. Supplement response varies, so testing is more reliable than guessing from capsule labels.

Food sources comparison

Source (3.5 oz / 100 g)	EPA	DHA	Best use
Atlantic mackerel	High	High	General EPA+DHA
Wild salmon	Moderate	High	DHA-forward food source
Sardines	Moderate	Moderate-high	Affordable frequent option
Herring	High	High	General EPA+DHA
Anchovies	Moderate	High	Small oily fish option
Algae oil	Varies	Often DHA-forward	Plant-based direct EPA/DHA
Flax, chia, walnuts	ALA only	No direct DHA	Healthy foods, but limited conversion

Two servings of fatty fish per week are enough for many general-health goals. Therapeutic triglyceride lowering is different and usually requires clinician-directed prescription dosing.

This information does not replace professional medical advice. Consult your healthcare provider before high-dose supplementation, especially if you take anticoagulants, have atrial fibrillation, are pregnant, or are preparing for surgery.

---

How to track and measure the effects

Key metrics

Metric	How to measure	Target	Timeline
Omega-3 Index	Blood spot test (OmegaQuant, etc.)	8–12%	Baseline + 4 months
Triglycerides	Standard lipid panel	<150 mg/dL (1.7 mmol/L)	Baseline + 3 months
hsCRP	Blood test	<1.0 mg/L	Baseline + 8 weeks
Resting heart rate	Wearable	Lower is better (within normal)	Weekly
HRV	Wearable overnight	Higher is better	Weekly
Blood pressure	Home cuff	<120/80 mmHg (optimal)	Weekly
Deep sleep	Wearable	13–23% of total sleep	Nightly

---

How SuperAge helps you optimize omega-3 status

Omega-3 supplementation is only useful if it actually moves your health metrics. SuperAge helps you track the outcomes that matter:

Cardiovascular monitoring

SuperAge tracks resting heart rate and heart rate variability — both directly influenced by omega-3 status. Higher HRV and lower resting heart rate are associated with better omega-3 levels and cardiovascular fitness.

Biological age tracking

SuperAge calculates your biological age from a composite of fitness and cardiovascular metrics. Optimizing your Omega-3 Index contributes to the cardiovascular, inflammatory, and recovery components of this score.

Progress over time

Whether you increase fish intake or start supplementing, SuperAge’s trend analysis shows whether your cardiovascular markers are actually improving — turning guesswork into data.

---

Frequently asked questions

Can I get enough DHA and EPA from plant-based sources?

ALA from flaxseed, chia, walnuts, and other plants converts inefficiently to EPA and even less efficiently to DHA. These foods are still healthy, but if you want direct EPA+DHA without fish, algae oil is the more reliable plant-based option.

Is it dangerous to take high-dose fish oil?

High-dose fish oil can be appropriate in specific medical contexts, especially high triglycerides, but it should not be treated as automatically safer because it is a supplement. Cardiovascular outcome trials and meta-analyses show a dose-related atrial-fibrillation signal, and omega-3 products can interact with anticoagulant or antiplatelet therapy. Use clinician guidance above routine food-level intake.

Should I take fish oil with food?

Yes. Taking omega-3 with a meal that contains fat improves absorption, especially for ethyl-ester forms. The exact boost depends on the formulation and meal composition, so the practical rule is simple: take it with your largest fat-containing meal and store the product properly.

How do I know if my omega-3 supplement is fresh?

Rancid fish oil may cause fishy burps, an unpleasant smell or taste, and exposure to oxidized lipids. Choose products with third-party testing when possible, check the expiration date, avoid heat and light, and refrigerate after opening if the label recommends it.

EPA or DHA for older adults?

Usually both. Older adults may benefit from DHA for brain and retinal structure and from EPA for triglycerides, inflammatory signaling, and cardiovascular context. A balanced or slightly DHA-forward formula is reasonable for general aging goals; EPA-dominant formulas make more sense when triglycerides, inflammation, or mood support are the main target.

---

Key takeaways

• DHA -> brain and retina: best prioritized when the goal is structural neural or eye support.
• EPA -> triglycerides, inflammation, mood: most useful when the goal is inflammatory signaling, triglycerides, or mood-support adjuncts.
• Omega-3 Index -> tracking: useful for EPA+DHA status, but mortality associations are observational, not guaranteed outcomes.
• REDUCE-IT -> prescription context: strong EPA event data came from high-risk patients using icosapent ethyl, not generic fish oil.
• High dose -> caution: discuss 2-4 g/day dosing if you have atrial-fibrillation risk, bleeding risk, anticoagulants, pregnancy, or surgery.
• Food first -> smarter baseline: fatty fish or algae can cover many general-health needs; supplements fill measured gaps.

---

Optimize your omega-3 status for longevity

The omega-3 ratio in your blood is one of the most modifiable predictors of cardiovascular and brain health as you age. Whether you eat more fish or supplement strategically, tracking the downstream effects on your body is what turns knowledge into results.

Ready to take control? Download SuperAge and start tracking how your cardiovascular fitness and biological age respond to the changes you make.

---

References

1. National Institutes of Health Office of Dietary Supplements. Omega-3 fatty acids: fact sheet for health professionals. NIH ODS
2. Harris WS, Tintle NL, Imamura F, et al. Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies. Nature Communications. 2021;12:2329. DOI
3. Bhatt DL, Steg PG, Miller M, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. New England Journal of Medicine. 2019;380:11-22. DOI
4. Gencer B, Djousse L, Al-Ramady OT, et al. Effect of long-term marine omega-3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes. Circulation. 2021;144:1981-1990. DOI
5. Liao Y, Xie B, Zhang H, et al. Efficacy of omega-3 PUFAs in depression: a meta-analysis. Translational Psychiatry. 2019;9:190. DOI
6. McNamara RK. Importance of EPA and DHA blood levels in brain structure and function. Nutrients. 2021;13:1074. DOI
7. Mozaffarian D, Wu JHY. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. Journal of the American College of Cardiology. 2011;58:2047-2067. DOI
8. Bazan NG. Neuroprotectin D1: a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathology. 2005;15:159-166. DOI

---

Last updated: June 2026. This article is regularly reviewed to ensure accuracy.